Jim Cramer

Jim Cramer explains how to spot ‘exquisite moments’ like Friday’s session
World

Jim Cramer explains how to spot ‘exquisite moments’ like Friday’s session

CNBC’s Jim Cramer reviewed Friday’s market action, dubbing the session an “exquisite moment,” where stocks opened weak, but the averages climbed by the close. While he said this particular moment has come and gone, he listed ways investors can recognize one in the future, saying these conditions can yield big gains. “We used to call […]

Read More
FedEx CEO touts company’s ‘scaled network’ as supply chain challenges loom with Trump presidency
World

FedEx CEO touts company’s ‘scaled network’ as supply chain challenges loom with Trump presidency

In a Thursday interview with CNBC’s Jim Cramer, FedEx CEO Raj Subramaniam said his company can do well even if there is a supply chain shakeup. “As the supply chain patterns change, we are here, there and everywhere,” he said. “That’s the advantage people sometimes miss, the fact that we have a scaled network in […]

Read More
After taking morning profits, we’re afternoon buyers of 2 stocks in an oversold market
Finance

After taking morning profits, we’re afternoon buyers of 2 stocks in an oversold market

We’re buying 25 shares of Home Depot at roughly $407 each and 14 shares of Blackrock at roughly $1,041. Following Tuesday’s trades, Jim Cramer’s Charitable Trust will own 200 shares of HD, increasing its weighting to 2.25% from about 2%. The Trust portfolio, used by the CNBC Investing Club, will own 75 shares of BLK […]

Read More
We’re adding to our position in a stock that just landed a big Wall Street endorsement
Health

We’re adding to our position in a stock that just landed a big Wall Street endorsement

Shortly after the opening the bell, we will be buying 300 shares of Bristol Myers Squibb at roughly $56.50. Following the trade, Jim Cramer’s Charitable Trust will own 1,200 shares of BMY, increasing its weighting in the portfolio to roughly 1.9% from about 1.4%. Wall Street’s stretch of bad breadth may have finally caught up […]

Read More
We want to boost our ownership of a portfolio stock that just boosted its dividend
Health

We want to boost our ownership of a portfolio stock that just boosted its dividend

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Thursday markets: Stocks are taking a breather after Wednesday’s big surge, especially in the Nasdaq Composite and the more narrow “Magnificent Seven” cohort. The yield on […]

Read More
Here are 7 key moments from Jim Cramer’s interview of Donald Trump from the NYSE
World

Here are 7 key moments from Jim Cramer’s interview of Donald Trump from the NYSE

President-elect Donald Trump told CNBC’s Jim Cramer on Thursday the stock market is “going to see a lot of good days ahead.” Jim interviewed Trump on the floor of the New York Stock Exchange moments after the president-elect rang the opening bell. In their wide-ranging discussion, Trump said the performance of the stock market is […]

Read More
Eli Lilly’s obesity drug beats rival in head-to-head trial — where Cramer sees shares going next
Health

Eli Lilly’s obesity drug beats rival in head-to-head trial — where Cramer sees shares going next

New trial data has cemented Club holding Eli Lilly ‘s pole position in the highly competitive obesity drug race. The news Eli Lilly’s obesity drug Zepbound bested its main rival Wegovy — made by Denmark’s Novo Nordisk — in the first head-to-head trial comparing the fast-growing weight loss treatments. Patients on Zepound lost an average […]

Read More
Our newest portfolio stock backed off its recent 52-week high — so we’re buying more
Health

Our newest portfolio stock backed off its recent 52-week high — so we’re buying more

We’re buying 300 shares of Bristol-Myers Squibb at roughly $58 each. Following Wednesday’s trade, Jim Cramer’s Charitable Trust will own 900 shares of BMY, increasing its weighting to about 1.5% from 1%. Shares of pharmaceutical maker Bristol-Myers have dropped about 3% in the past two days in the absence of any real news. The stock […]

Read More
Jim Cramer’s big takeaway from the market reaction to Nvidia’s earnings beat
World

Jim Cramer’s big takeaway from the market reaction to Nvidia’s earnings beat

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Thursday’s key moments. 1. Wall Street is having a mixed session Thursday. While the Dow Jones Industrial Average was slightly higher, the S & P 500 and tech-heavy Nasdaq Composite gave up earlier […]

Read More
Jim Cramer wants to buy this falling tech stock — and touts another reason to like Disney
World

Jim Cramer wants to buy this falling tech stock — and touts another reason to like Disney

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. 1. Stocks were in the red Wednesday, led to the downside by the Nasdaq Composite. The tech-heavy index was weighed down by Nvidia slipping 2% ahead of its earnings after […]

Read More